Surgical Management of Vestibular Schwannomas Post-Stereotactic Radiosurgery: Findings from a Study at the University of Pittsburgh Medical Center

A recent study conducted at the University of Pittsburgh Medical Center has investigated the surgical management of vestibular schwannomas (VS) after tumor progression following stereotactic radiosurgery (SRS). The study aimed to assess whether surgical and facial nerve outcomes are influenced by the extent of resection after failed SRS. The findings of this research have significant implications for the treatment of VS.

Key Takeaways:

  • The study included 22 patients with VS post-SRS progression who underwent surgical resection over a period of three decades at the University of Pittsburgh Medical Center.
  • The patients were divided into three groups based on the extent of resection: gross total (GTR) resection (n = 4), near-total (NTR) resection (n = 10), and subtotal (STR) resection (n = 8).
  • The study found that patients in the STR group had significantly better facial nerve preservation compared to those in the GTR/NTR group, with no deterioration noted among these patients.
  • The STR group had a comparable complication rate to the GTR/NTR group, with both groups exhibiting 100% tumor control at last follow-up with comparable follow-up duration.
  • The study suggests that radical resection might not be necessary for tumor control after failed SRS for VS.

Statistics:

  • 22 patients with VS post-SRS progression underwent surgical resection over a period of three decades at the University of Pittsburgh Medical Center.
  • The patients were divided into three groups based on the extent of resection: GTR (n = 4), NTR (n = 10), and STR (n = 8).
  • 7 patients in the GTR/NTR group experienced worsening of facial function, while 4 patients in the STR group had no facial function deterioration.
  • 100% tumor control was achieved in both the GTR/NTR and STR groups at last follow-up, with a comparable follow-up duration of 90.8 months (range: 11.8-155.8) and 100.6 months (range: 0.5-232), respectively.

Sources:

  • Facial Nerve Outcomes After Resection of Aggressive Vestibular Schwannomas That Failed Initial Stereotactic Radiosurgery. Neurosurgery, 2025.
  • NewsRx. Studies from University of Pittsburgh Medical Center Provide New Data on Vestibular Schwannoma (Facial Nerve Outcomes After Resection of Aggressive Vestibular Schwannomas That Failed Initial Stereotactic Radiosurgery). Health & Medicine Week. October 31, 2025; p 2144.